2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Familial Primary Pulmonary Hypertension in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Familial Primary Pulmonary Hypertension: Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantoni, S | 1 |
Galletti, M | 1 |
Zambelli, F | 1 |
Valente, S | 1 |
Ponti, F | 1 |
Tassinari, R | 1 |
Pasquinelli, G | 1 |
Galiè, N | 1 |
Ventura, C | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Familial Primary Pulmonary Hypertension
Article | Year |
---|---|
Sodium butyrate inhibits platelet-derived growth factor-induced proliferation and migration in pulmonary artery smooth muscle cells through Akt inhibition.
Topics: Acetylation; Animals; Butyric Acid; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cell | 2013 |